- Discovery of Potent Antiallergic Agents Based on ano-Aminopyridinyl Alkynyl Scaffold
-
Effective therapeutic agents are highly desired for immune-mediated allergic diseases. Herein, we report the design, synthesis, and structure-activity relationship of ano-aminopyridinyl alkyne series as novel orally bioavailable antiallergic agents, which
- Bai, Fang,Chen, Taiwen,Fan, Chen,Hu, Youhong,Li, Xin,Liu, Moting,Ma, Yanjie,Tang, Wei,Xiang, Caigui,Xie, Zhicheng
-
supporting information
p. 13588 - 13603
(2021/09/20)
-
- Glycine receptor antagonists and the use thereof
-
Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions, inducing anesthesia and treating psychosis are disclosed by administering to an animal in need of such treatment a compound having high affinity for the glycine binding site, lacking PCP side effects and which crosses the blood brain barrier of the animal. Also disclosed are novel 1,4-dihydroquinoxaline-2,3-diones, and pharmaceutical compositions thereof. Also disclosed are highly soluble ammonium salts of 1,4-dihydroquinoxaline-2,3-diones.
- -
-
-
